Literature DB >> 18166325

Evaluation of physiological alterations of the placenta through analysis of cell-free messenger ribonucleic acid concentrations of angiogenic factors.

Yuditiya Purwosunu1, Akihiko Sekizawa, Antonio Farina, Noroyono Wibowo, Keiko Koide, Shiho Okazaki, Masamitsu Nakamura, Takashi Okai.   

Abstract

OBJECTIVE: Placental messenger ribonucleic acid (mRNA) has been shown to circulate in maternal plasma. We investigated concentrations of vascular endothelial growth factor (VEGF), VEGF receptor-1 (VEGFR-1), and endoglin in subjects with preeclampsia, compared with normal pregnancies. STUDY
DESIGN: Peripheral blood samples were obtained from preeclampsia (n = 43) and control subjects (n = 41). Plasma ribonucleic acid was subjected to analysis by reverse transcription-polymerase chain reaction assay to examine the mRNA distribution among women with preeclampsia and control subjects during weeks 35-41 of gestation.
RESULTS: Concentrations of VEGF, VEGFR-1, and endoglin mRNA of women with preeclampsia were significantly increased. The mRNA values were observed to correlate directly with the severity of hypertension and proteinuria. VEGFR-1 mRNA was markedly elevated in women with preeclampsia and hemolysis, elevated liver enzymes, and low platelet syndrome.
CONCLUSION: The mRNA concentrations of VEGF, VEGFR-1, and endoglin were observed to correlate directly with the severity of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18166325     DOI: 10.1016/j.ajog.2007.06.079

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  6 in total

Review 1.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

2.  Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.

Authors:  Jeffry Iman Gurnadi; Johannes Mose; Budi Handono; Mieke H Satari; Anita Deborah Anwar; Prima Nanda Fauziah; A Yogi Pramatirta; Dwi Davidson Rihibiha
Journal:  BMC Res Notes       Date:  2015-10-04

Review 3.  A systematic review of endoglin gene expression in preeclampsia.

Authors:  Mandy J Bell; Yvette P Conley
Journal:  Biol Res Nurs       Date:  2011-09-15       Impact factor: 2.522

4.  Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.

Authors:  Alain F Tanbe; Raouf A Khalil
Journal:  Curr Bioact Compd       Date:  2010-03-01

Review 5.  Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Stephanie J Sheppard; Raouf A Khalil
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-03

6.  Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia.

Authors:  M L Martinez-Fierro; I Garza-Veloz; K Carrillo-Sanchez; V Martinez-Gaytan; R Cortes-Flores; M A Ochoa-Torres; G G Guerrero; I P Rodriguez-Sanchez; C O Cancela-Murrieta; M Zamudio-Osuna; J I Badillo-Almaraz; C Castruita-De la Rosa
Journal:  Hypertens Pregnancy       Date:  2013-12-02       Impact factor: 2.108

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.